^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Gliadel Wafer (carmustine implant)

Associations
Company:
Azurity Pharma, Eisai
Drug class:
Alkylating agent
Related drugs:
Associations
Phase 2
University of Nebraska
Completed
Last update posted :
10/06/2023
Initiation :
05/08/2002
Primary completion :
11/01/2005
Completion :
03/12/2015
CD20
|
CD20 positive
|
Rituxan (rituximab) • cytarabine • etoposide IV • carmustine • melphalan • Gliadel Wafer (carmustine implant) • captisol-enabled melphalan